# Blue Ridge Bankshares, Inc.: overview

BRBS · NYSE · CIK 842717 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/brbs.md) · [Financials](/companies/brbs/financials.md) · [Filings](/companies/brbs/filings.md) · [Insiders](/companies/brbs/insiders.md)

Latest reported revenue: [$37.3m](/filings/0000950170-21-004166.md) for Q3 FY2021, three months to 2021-09-30, from the 10-Q filed Nov 10, 2021 (XBRL us-gaap:Revenues, accession 0000950170-21-004166).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.01](/filings/0001193125-25-264940.md) | not reported | [(0.01)](/filings/0001193125-26-206547.md) | [0.01](/filings/0001193125-26-342578.md) | [0.06](/filings/0001193125-25-264940.md) | not reported | [0.01](/filings/0001193125-26-206547.md) | [(0.01)](/filings/0001193125-26-342578.md) |
| Free cash flow | $m | [23.9 d](/filings/0001193125-25-264940.md) | [(18.2) d](/filings/0001193125-26-104410.md) | [(3.6)](/filings/0001193125-26-206547.md) | [10.5 d](/filings/0001193125-26-342578.md) | [5.7 d](/filings/0001193125-25-264940.md) | [(0.7) d](/filings/0001193125-26-104410.md) | [14.6](/filings/0001193125-26-206547.md) | [1.5 d](/filings/0001193125-26-342578.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [2.94](/filings/0000950170-24-032267.md) | [0.92](/filings/0000950170-24-032267.md) | [(2.73)](/filings/0000950170-25-036301.md) | [(0.31)](/filings/0001193125-26-104410.md) | [0.11](/filings/0001193125-26-104410.md) |
| Free cash flow | $m | [58.0](/filings/0000950170-24-032267.md) | [93.5](/filings/0000950170-24-032267.md) | [43.1](/filings/0000950170-25-036301.md) | [(6.9)](/filings/0001193125-26-104410.md) | [11.9](/filings/0001193125-26-104410.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/brbs/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $22.2m | 6,296,410 |  | Reduced −136,151 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $15.0m | 4,260,106 |  | Added +465,127 |
| [ALGEBRIS (UK) LTD](/funds/1700286.md) | 2026-06-30 | $9.0m | 2,553,967 |  | Added +18,862 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $8.6m | 2,428,754 |  | Reduced −200,822 |
| [BANC FUNDS CO LLC](/funds/1029311.md) | 2026-06-30 | $6.7m | 1,889,033 |  | Unchanged |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $4.7m | 1,341,091 |  | Added +69,150 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $4.0m | 1,133,307 |  | Added +207,766 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $3.8m | 1,090,269 |  | Reduced −4,700 |
| [GRAHAM CAPITAL WEALTH MANAGEMENT, LLC](/funds/1907528.md) | 2026-06-30 | $3.6m | 1,025,916 |  | Added +8,984 |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $3.4m | 812,162 |  | Reduced −69,334 |

## Recent filings

[All 602 filings](/companies/brbs/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 17:00 ET | [8-K](/filings/0001193125-26-432133.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-432133 |
| 2026-08-17 | 08:35 ET | [8-K](/filings/0001193125-26-353285.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-353285 |
| 2026-08-10 | 16:51 ET | [10-Q](/filings/0001193125-26-342578.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342578 |
| 2026-08-10 | 16:15 ET | [8-K/A](/filings/0001193125-26-342413.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342413 |
| 2026-07-28 | 17:15 ET | [8-K](/filings/0001193125-26-321256.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-321256 |
| 2026-06-18 | 15:44 ET | [8-K/A](/filings/0001193125-26-275716.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-275716 |
| 2026-06-18 | 11:56 ET | [8-K](/filings/0001193125-26-275393.md) | 5.07 Shareholder vote results | 0001193125-26-275393 |
| 2026-05-28 | 16:30 ET | [8-K](/filings/0001193125-26-245321.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-245321 |
| 2026-05-05 | 16:30 ET | [10-Q](/filings/0001193125-26-206547.md) | Quarterly report, period 2026-03-31 | 0001193125-26-206547 |
| 2026-04-30 | 15:16 ET | [DEF 14A](/filings/0001193125-26-196703.md) | Proxy statement, period 2026-04-30 | 0001193125-26-196703 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-104410.md), filed Mar 12, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 842717
- Tickers: BRBS
- Exchange: NYSE
- SIC code: 6022 State Commercial Banks
- State of incorporation: VA
- Filer category: Accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 17:01 ET. No prices; not investment advice.
